+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Clinical Trial Site Management Organizations Market Size, Share & Trends Analysis Report by Clinical Trail Service/Component, Phase, Therapeutic Areas (Oncology, Cardiology, CNS), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 275 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5595822
Description Jump to:
The global clinical trials site management organizations market size is expected to reach USD 9.47 billion by 2030, according to the report. The market is expected to expand at a CAGR of 6.17% from 2024 to 2030. Site management organizations (SMOs) are essential elements of pharmaceutical and biopharmaceutical companies. Such organizations help to limit the burden associated with clinical research. SMOs offer several services including patient enrollment services, addressing clinical trial location-specific study activities, hiring study staff, and monitoring clinical studies site operations. Improved technological use in integrated site networks and clinical trial services, increasing trend of outsourced clinical services, and growing clinical trial activities globally owing to the high burden of chronic and infectious diseases, are few of the factors driving the market.

Technology has improved efficiencies at the site level by improving metrics such as on-site identification, selection, and performance, as well as throughout the patient spectrum by analyzing recruitment, enrollment, selection, retention, and compliance measures at sites. Furthermore, technical improvements have resulted in enhanced biostatistics and data analytics analysis to better evaluate a drug's feasibility early in the development phase. As a result of the COVID-19 pandemic, several organizations were forced to halt operations while others were forced to completely shut down. However, the SMOs execute multi-eccentric trials effectively to save the firm money and time.

Manual processes and paperwork are replaced by digital technologies to limit the negative impact of the pandemic on the business. Due to this, Site Management Organization facilitates detailed documentation while also streamlining the procedure in any clinical research, even when physical contact is nearly impossible to prevent viral spread. SMO's efficient follow-up skills along with the adoption of virtual technologies to conduct clinical research have significantly decreased the time required to recruit patients. As new virus strains are being discovered in different areas of the world, research would remain a top focus. SMOs would be required by health and biotech companies for data collection, participant or patient safety, patient recruitment, more accurate doctor contact information, and other tasks. Hence, such factors are supporting the rebound of revenues across the market during 2021.

Clinical Trials Site Management Organizations Market Report Highlights

  • The project management segment dominated the market with a revenue share of 25.0% in 2023, due to the fact that it is required to ensure that clinical trials are set up, enrolled, reported on time, and conducted within the budget
  • The phase III segment accounted for the largest revenue share of 54.16% in 2023. This growth is attributed to the fact that phase III trials are often the largest and involve thousands of participants and are the most expensive ones
  • Based on therapeutic area, the oncology segment is anticipated to witness the fastest CAGR of 6.66% in the market during the forecast period, due to the high global prevalence of cancer, which is generating demand for drugs and thus increasing its market share
  • Asia Pacific led the market in 2023 and is projected to witness the fastest CAGR of 6.87% during the forecast years, as cost-effective strategic solutions provided by SMOs could reduce timelines, as in changing market for clinical trials, fast recruitment, and a huge pool of patients are some of the prerequisites


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis (model 1)
1.6.2. Volume Price Analysis (model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. List of Abbreviations
1.10 Objectives
1.10.1. Objective - 1
1.10.2. Objective - 2
1.10.3. Objective - 3
1.10.4. Objective - 4
Chapter 2 Executive Summary
2.1. Market Outlook
Chapter 3 Clinical Trial Site Management Organizations (SMOs) Market: Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1 Growth in the number of clinical Studies
3.2.1.2. Rising investment in R&D by the pharmaceutical companies.
3.2.1.3. Increasing rate of clinical trials outsourcing by pharmaceutical and biopharmaceutical companies.
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of clinical studies
3.2.2.2. Presence of significant CROs offering site management services possesses the threat to steal its market share
3.3. Penetration & Growth Prospect Mapping
3.4. COVID-19 Impact on the Market
3.5. Major Deals and Strategic Alliances Analysis
3.6. Clinical Trial Site Management Organizations (SMO)s: Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.2. PESTEL Analysis
Chapter 4 Clinical Trial Site Management Organizations (SMOs) Market: Clinical Trial Services/ Components Segment Analysis
4.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
4.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
4.3 Site Management
4.3.1 Site Management Market, 2018 - 2030 (USD Million)
4.4 Project Management
4.4.1 Project Management market, 2018 - 2030 (USD Million)
4.5 Onsite Monitoring
4.5.1 Onsite Monitoring market, 2018 - 2030 (USD Million)
4.6 Regulatory
4.6.1 Regulatory Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1 Others market, 2018 - 2030 (USD Million)
Chapter 5 Clinical Trial Site Management Organizations (SMOs) Market: Phase Analysis
5.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
5.2 Clinical Trial Site Management Organizations (SMO) : Market Share Analysis, 2023 & 2030
5.3 Phase I
5.3.1 Phase I Market, 2018 - 2030 (USD Million)
5.4. Phase II
5.4.1 Phase II Market, 2018 - 2030 (USD Million)
5.5 Phase III
5.5.1. Phase III Market, 2018 - 2030 (USD Million)
5.6 Phase IV
5.6.1. Phase IV Market, 2018 - 2030 (USD Million)
Chapter 6 Clinical Trial Site Management Organizations (SMOs) Market: Therapeutic Area Analysis
6.1 Clinical Trial Site Management Organizations (SMOs) Market: Definition & Scope
6.2 Clinical Trial Site Management Organizations (SMO): Market Share Analysis, 2023 & 2030
6.3 Oncology
6.3.1 Oncology Market, 2018 - 2030 (USD Million)
6.4. Cardiology
6.4.1 Cardiology Market, 2018 - 2030 (USD Million)
6.5 CNS
6.5.1. CNS Market, 2018 - 2030 (USD Million)
6.6 Pain Management
6.6.1. Pain Management Market, 2018 - 2030 (USD Million)
6.7 Endocrine
6.7.1. Endocrine Market, 2018 - 2030 (USD Million)
6.8 Others
6.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7 Clinical Trial Site Management Organizations (SMOs) Market: Regional Analysis
7.1 Clinical Trial Site Management Organizations (SMO): Market Share Analysis
7.2 North America
7.2.1 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
7.3.7 Denmark
7.3.7.1 Denmark Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Sweden Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Norway Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030(USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.2 India
7.4.2.1 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.4 China
7.4.4.1 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Thailand Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 Clinedge
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Service Benchmarking
8.1.1.4 Strategic Initiative
8.1.2 WCG
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Service Benchmarking
8.1.2.4 Strategic Initiative
8.1.3 ClinChoice
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Service Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Access Clinical Research
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Service Benchmarking
8.1.4.4 Strategic Initiatives
8.1.5 FOMAT Medical Research INC.
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Service Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 SGS
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Service Benchmarking
8.1.6.4 Strategic Initiatives
8.1.7 KV Clinical
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Service Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 SMO-Pharmina
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Service Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Xylem Clinical Research
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Service Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 Aurum Clinical Research
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Service Benchmarking
8.1.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 4 Global Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 5 Global Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 6 Global Clinical Trial Site Management Organizations (SMOs) Market, by Region, 2018 - 2030 (USD Million)
Table 7 North America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 9 North America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 10 North America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 11 US Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 12 US Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 13 US Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 14 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 15 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 16 Canada Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 17 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 19 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 20 Europe Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 21 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 22 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 23 Germany Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 24 UK Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 25 UK Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 26 UK Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 27 France Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 28 France Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 29 France Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 30 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 31 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 32 Italy Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 33 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 34 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 35 Spain Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 36 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 37 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 38 Denmark Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 39 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 40 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 41 Sweden Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 42 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 43 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 44 Norway Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 49 China Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 50 China Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 51 China Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 52 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 53 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 54 Japan Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 55 India Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 56 India Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 57 India Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 58 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 59 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 60 South Korea Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 61 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 62 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 63 Australia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 64 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 65 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 66 Thailand Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 67 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
Table 68 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 69 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 70 Latin America Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 71 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 72 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 73 Brazil Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 74 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 75 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 76 Mexico Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 77 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 78 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 79 Argentina Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 84 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 85 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 86 South Africa Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 90 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 91 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 92 UAE Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 93 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Services/ Components, 2018 - 2030 (USD Million)
Table 94 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Phase, 2018 - 2030 (USD Million)
Table 95 Kuwait Clinical Trial Site Management Organizations (SMOs) Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Clinical Trial Site Management Organizations (SMOs) Market, Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Regional Marketplace: Key Takeaways
Fig. 12 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase I, 2018 - 2030 (USD Million)
Fig. 13 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase II, 2018 - 2030 (USD Million)
Fig. 14 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase III, 2018 - 2030 (USD Million)
Fig. 15 Global Clinical Trial Site Management Organizations (SMOs) Market, for Phase IV, 2018 - 2030 (USD Million)
Fig. 16 Global Clinical Trial Site Management Organizations (SMOs) Market, for Site Management, 2018 - 2030 (USD Million)
Fig. 17 Global Clinical Trial Site Management Organizations (SMOs) Market, for Project Management, 2018 - 2030 (USD Million)
Fig. 18 Global Clinical Trial Site Management Organizations (SMOs) Market, for Regulatory , 2018 - 2030 (USD Million)
Fig. 19 Global Clinical Trial Site Management Organizations (SMOs) Market, for Onsite Monitoring, 2018 - 2030 (USD Million)
Fig. 20 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others , 2018 - 2030 (USD Million)
Fig. 21 Global Clinical Trial Site Management Organizations (SMOs) Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 22 Global Clinical Trial Site Management Organizations (SMOs) Market, for Cardiology , 2018 - 2030 (USD Million)
Fig. 23 Global Clinical Trial Site Management Organizations (SMOs) Market, for CNS, 2018 - 2030 (USD Million)
Fig. 24 Global Clinical Trial Site Management Organizations (SMOs) Market, for Pain Management, 2018 - 2030 (USD Million)
Fig. 25 Global Clinical Trial Site Management Organizations (SMOs) Market, for Enodcrine, 2018 - 2030 (USD Million)
Fig. 26 Global Clinical Trial Site Management Organizations (SMOs) Market, for Others, 2018 - 2030 (USD Million)
Fig. 27 Regional Outlook, 2021 & 2030
Fig. 28 North America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 29 U.S. Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 30 Canada Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 31 Europe Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 32 Germany Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 33 UK Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 34 France Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 35 Italy Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 36 Spain Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 38 Japan Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 39 China Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 40 India Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 41 Australia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 42 South Korea Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 43 Latin America Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 44 Brazil Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 45 Mexico Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 46 Argentina Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 47 Colombia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 49 South Africa Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)
Fig. 51 UAE Clinical Trial Site Management Organizations (SMOs) Market, 2018 - 2030 (USD Million)

Companies Profiled

  • Clinedge
  • Wcg
  • Clinchoice
  • Access Clinical Research
  • Fomat Medical Research Inc.
  • Sgs
  • Kv Clinical
  • Smo-Pharmina
  • Xylem Clinical Research
  • Aurum Clinical Research

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages275
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 6.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.47 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Clinical Trial Site Management Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Clinical Trial Site Management Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 178 Pages
  • Global
From
Clinical Trial Site Management Organization Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Clinical Trial Site Management Organization Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 255 Pages
  • Global
From
Global In Vivo CRO Market Size, Share & Trends Analysis Report by Model Type (Rodent Based, Non-rodent Based), Modality (Small Molecule, Large Molecule), Indication, GLP Type (Non GLP, GLP Toxicology), Region, and Segment Forecasts, 2024-2030 - Product Image

Global In Vivo CRO Market Size, Share & Trends Analysis Report by Model Type (Rodent Based, Non-rodent Based), Modality (Small Molecule, Large Molecule), Indication, GLP Type (Non GLP, GLP Toxicology), Region, and Segment Forecasts, 2024-2030

  • Report
  • 257 Pages
  • Global
From
Global Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas - Forecast 2024-2030 - Product Image

Global Clinical Trials Site Management Organizations Market by Phase (Phase I, Phase II, Phase III), Services (Onsite Monitoring, Project Management, Regulatory Compliance), Therapeutic Areas - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age group, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report By Service Type, By Phase, By Therapeutic Area, By Age group, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.